Aus­tralia’s Cochlear plans expansion in China

BioSpectrum (Asia) - - Finance News -

Bionic ear im­plant maker Cochlear is ex­pand­ing its global man­u­fac­tur­ing ca­pac­ity with a new $50 mil­lion fa­cil­ity in China. Cochlear will build the plant in the west­ern Chi­nese city of Chengdu and hopes to have the first units rolling off the assem­bly line in four years once it has gained the nec­es­sary reg­u­la­tory ap­provals. At full pro­duc­tion, the plant will boost Cochlear’s im­plant pro­duc­tion ca­pac­ity by 50 per cent. China is al­ready among Cochlear’s top five in­ter­na­tional mar­kets and is its fastest grow­ing mar­ket by vol­ume, with po­ten­tial to de­liver more strong growth over the next decade. Cochlear has pre­vi­ously man­u­fac­tured the im­plants only in Aus­tralia, although it has plants for other prod­ucts in the United States, Swe­den and Bel­gium it owns fol­low­ing ac­qui­si­tions. Cochlear is based in Syd­ney, on the Mac­quarie Univer­sity cam­pus, and has a man­u­fac­tur­ing fa­cil­ity there, along with oth­ers in Lane Cove and Bris­bane.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.